Threshold US · Senior housing

Nursing home supply in Arizona

140 certified nursing homes · 15,984 certified beds · CMS Care Compare
140
certified nursing homes
15,984
certified beds
114
average beds per home
4,751
beds in 1 or 2-star homes (at-risk supply)

CMS rating mix

Certified beds by CMS overall 5-star rating across Arizona. Beds in 1 and 2-star homes are supply that may not survive, and therefore latent replacement demand.

5-star4,176 beds
4-star2,823 beds
3-star4,093 beds
2-star3,521 beds
1-star1,230 beds
Not rated141 beds

Largest markets by beds

CityHomesBeds
Tucson212,838
Phoenix232,784
Mesa111,491
Scottsdale111,036
Glendale6970
Peoria5796
Yuma6632
Chandler5496

Ownership

Ownership typeHomesBeds
For Profit - Corporation576,973
For Profit - Limited Liability Company576,480
Non Profit - Corporation11765
For Profit - Partnership5583
For Profit - Individual4497

Largest nursing homes

HomeCityBedsCMS rating
Devon Gables Rehabilitation CenterTucson3122-star
Sandstone Of Tucson Rehab CentreTucson2402-star
Casas Adobes Post Acute Rehab CenterTucson2303-star
Immanuel Campus Of CarePeoria2282-star
Providence Place At GlencroftGlendale2253-star
Life Care Center Of North GlendaleGlendale2235-star
Montecito Post Acute Care And RehabilitationMesa2225-star
Life Care Center Of Paradise ValleyPhoenix2103-star

The demand gap

Coming shortly: the population aged 85+ in each catchment and the demand gap against the national rate, from US Census Bureau data (being finalized). Supply above is live now from CMS. Join the waitlist to be first in when the Arizona demand analysis goes live.

Appraise any Arizona site in 60 seconds

Threshold US Care is launching in 2026. Drop a pin anywhere in Arizona: every competing certified bed and its CMS rating, the demand gap, and the maximum land bid. Reserve founding access for Arizona now.

Join the Arizona waitlist

All states → · The US senior care gap →

Supply: CMS Care Compare Provider Information (public domain), latest release. Every figure is a statistical estimate for site screening, not a USPAP appraisal or investment advice.